Elafibranor Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 80 mg
Reference Brands: Iqirvo (USA/EU)
Category: Gastrointestinal Drugs
Elafibranor is an oral dual PPAR-α and PPAR-δ agonist used for the treatment of primary biliary cholangitis. It helps improve liver function, reduce bile acid accumulation, and lower inflammation, supporting better long-term liver health. Elafibranor is available in Tablets and strengths such as 80 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Elafibranor is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
| Technical Specifications & Supply Details | |
|---|---|
| Lead Time | 7 to 60 days (depending on batch size & schedule) |
| MOQ | As per manufacturer’s batch size |
| COA | Available with every batch |
| Regulatory Dossier / DMF | Available upon request |
| Export Documentation | FSC, COA, Manufacturing License, Product Permission |
| Standards | IP, BP, USP |
| Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Elafibranor can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Elafibranor is used for treating primary biliary cholangitis in adults who do not respond adequately to ursodeoxycholic acid or cannot tolerate it. It works as a dual PPAR-α/δ agonist that helps reduce liver inflammation and improve bile flow.
Elafibranor is made from the active ingredient elafibranor, a synthetic peroxisome proliferator-activated receptor (PPAR) agonist that targets metabolic and inflammatory pathways involved in cholestatic liver disease.
The trade name is Iqirvo.
Iqirvo is manufactured and marketed by Ipsen in collaboration with Genfit, the company that originally developed the drug.
The generic name is elafibranor.
The brand name is Iqirvo.
Elafibranor is manufactured in Europe and the United States through Ipsen’s and Genfit’s regulated pharmaceutical production facilities.
Related Products
Naloxegol Oxalate
Strength:
12.5 mg, 25 mg
Form: Tablets
Reference Brands: Movantik (USA), Moventig (EU)
View Details
Methscopolamine Bromide
Strength:
2.5 mg, 5 mg
Form: Tablets
Reference Brands: Pamine (USA)
View Details
Quick Response Guaranteed | Verified Suppliers
